RFK Jr. Could Advance Marijuana And Psychedelics Reform Agenda As Trump’s Top Health Official
President-elect Donald Trump has named Robert F. Kennedy Jr. as his pick to lead the U.S. Department of Health and Human Services
Browsing: medical
What We Know About Cannabis Far Exceeds What We Don’t
Contrary to common perception, what we know about cannabis far exceeds what we don’t.
Cannabis Can Help Some People – But Not Everyone – Sleep
Many insomniacs swear by cannabis as a way to help them sleep – while many scientific studies have found that THC actually exacerbates sleep problems.
Medical Marijuana Improves Chronic Pain And Mental Health, Reduces Prescription Drug Use
Results of a new yearlong study of prescribed medical marijuana for patients with chronic pain
No Link Found Between Prenatal Cannabis Use And Early Childhood Disorders
Two large studies looked for developmental disorders and autism in children of mothers who used cannabis in early pregnancy.
Canadian Medical Cannabis Outcomes Study Kicks Off
A long-established medical cannabis clinic and research organisation in Canada has begun recruitment for a study of patient outcomes from personalised medical cannabis treatment plans.
Cannabis Oil Can Help Heal Skin Wounds By Helping Tissue Regeneration
A new scientific review says cannabis oil may help promote the healing of skin wounds, finding that it offers “promising benefits”
Marijuana Components Show ‘Promising Potential As Anticancer Agents’, Study Finds
A new scientific review on cannabis and cancer concludes that a variety of cannabinoids—including delta-9 THC, CBD and cannabigerol (CBG)—”show promising potential as anticancer agents
Research Unpacks Impact of Cannabis Legalization on Medical Sales
With Oct. 17 marking the sixth anniversary of Canada’s legalization of recreational cannabis, a Brock researcher says it’s time to examine how the process has impacted the medical cannabis market.
A New Era For Cannabis And What It Could Mean For You
The U.S. government recently proposed rescheduling cannabis from a Schedule I to a Schedule III drug — basically signaling it has some accepted medical use
